BIO-key Seeks Shareholder Nod for M&K CPAs as New Auditor After Dismissing Bush & Associates
BKYI sits 47% above its 52-week low of $3.1 on light trading volume (0.2× avg).
Summary
BIO-key's definitive proxy for its September 3 annual meeting asks shareholders to ratify newly hired auditor M&K CPAs, following the July 2 dismissal of Bush & Associates. The auditor change adds a governance red flag to an already distressed company facing going concern doubts and recent Nasdaq delisting proceedings.
Key Events · Corporate Governance and Compliance · BKYI
-
Auditor Ratification Vote
Shareholders will vote on ratifying M&K CPAs, PLLC as the independent auditor for fiscal 2026. M&K was engaged on July 2, 2026, the same day Bush & Associates was dismissed.
-
Recent Auditor Dismissal
Bush & Associates was dismissed on July 7, 2026, after serving since April 2024. Its audit reports for 2024 and 2025 included going concern explanatory paragraphs but no adverse opinions or disagreements.
-
Governance Red Flag
The auditor change, occurring amid going concern warnings, a recent Nasdaq delisting notice, and a reverse stock split, raises concerns about financial reporting stability.
-
Annual Meeting Set for September 3
The meeting will also include election of five directors and an advisory say-on-pay vote. The record date is July 15, 2026, with 1,087,360 shares outstanding.
Analysis · BKYI · Technology
Just weeks after dismissing Bush & Associates on July 2, BIO-key is asking shareholders to ratify M&K CPAs as its independent auditor for 2026. The change lands against a backdrop of going concern warnings, a Nasdaq delisting scare, and a recent reverse stock split — turning the ratification vote into a key governance signal. While the proxy also covers routine director elections and say-on-pay, the auditor ratification stands out given the company's fragile financial position and the abrupt dismissal of the prior firm.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 35.8% of the 1190 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BKYI was trading at $4.55 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.9M. The 52-week trading range was $3.10 to $19.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.